| 000 | 01505 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518000345.0 | ||
| 264 | 0 | _c20181211 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1502-7708 | ||
| 024 | 7 |
_a10.1080/00365521.2018.1495260 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerrella, A | |
| 245 | 0 | 0 |
_aLate HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? _h[electronic resource] |
| 260 |
_bScandinavian journal of gastroenterology _c08 2018 |
||
| 300 |
_a1025-1026 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aItaly _xepidemiology |
| 650 | 0 | 4 |
_aLiver Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 700 | 1 | _aIzzi, A | |
| 700 | 1 | _aPunzi, R | |
| 700 | 1 | _aAdinolfi, E | |
| 700 | 1 | _aSbreglia, C | |
| 700 | 1 | _aBellopede, P | |
| 700 | 1 | _aGaleota Lanza, A | |
| 700 | 1 | _aMartucci, F | |
| 700 | 1 | _aRinaldi, L | |
| 773 | 0 |
_tScandinavian journal of gastroenterology _gvol. 53 _gno. 8 _gp. 1025-1026 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00365521.2018.1495260 _zAvailable from publisher's website |
| 999 |
_c28851697 _d28851697 |
||